Umut Ozbek, PhD
img_Umut Ozbek
ASSOCIATE PROFESSOR | Population Health Science and Policy

BS, Middle East Technical University

MS, Ankara University

PhD, University of Pittsburgh

Publications

Selected Publications

Erratum: Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer (Cell (2023) 186(16) (3476–3498.e35), (S0092867423007377), (10.1016/j.cell.2023.07.004)). Shrabanti Chowdhury, Jacob J. Kennedy, Richard G. Ivey, Oscar D. Murillo, Noshad Hosseini, Xiaoyu Song, Francesca Petralia, Anna Calinawan, Sara R. Savage, Anna B. Berry, Boris Reva, Umut Ozbek, Azra Krek, Weiping Ma, Felipe da Veiga Leprevost, Jiayi Ji, Seungyeul Yoo, Chenwei Lin, Uliana J. Voytovich, Yajue Huang, Sun Hee Lee, Lindsay Bergan, Travis D. Lorentzen, Mehdi Mesri, Henry Rodriguez, Andrew N. Hoofnagle, Zachary T. Herbert, Alexey I. Nesvizhskii, Bing Zhang, Jeffrey R. Whiteaker, David Fenyo, Wilson McKerrow, Joshua Wang, Stephan C. Schürer, Vasileios Stathias, X. Steven Chen, Mary Helen Barcellos-Hoff, Timothy K. Starr, Boris J. Winterhoff, Andrew C. Nelson, Samuel C. Mok, Scott H. Kaufmann, Charles Drescher, Marcin Cieslik, Pei Wang, Michael J. Birrer, Amanda G. Paulovich. Cell

Emotional and Financial Stressors in New York City During the COVID-19 Pandemic: A Consecutive Cross-Sectional Analysis. David J. Heller, Devin Madden, Timnit Berhane, Nina A. Bickell, Grace Van Hyfte, Sarah Miller, Umut Ozbek, Jung Yi Lin, Rebecca M. Schwartz, Robert A. Lopez, Guedy Arniella, Victoria Mayer, Carol R. Horowitz, Emma K. Benn, Nita Vangeepuram. Journal of racial and ethnic health disparities

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan Grupp, Sigrun Gleich, Ernst Holler, Nora Rebeka Javorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory Yanik, Rachel Young, Yi Bin Chen, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine. Blood advances

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ozbek during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Eli Lilly And Company

Outside Employment:

  • Eli Lilly And Company

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.